Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Medulloblastoma Stories

2014-03-27 12:30:55

A St. Jude Children's Research Hospital-led study identified two adult cancer drugs with potential to improve treatment of a high-risk childhood brain tumor; the drugs are now part of a pediatric clinical trial MEMPHIS, Tenn., March 27, 2014 /PRNewswire-USNewswire/ -- The quest to improve survival of children with a high-risk brain tumor has led St. Jude Children's Research Hospital investigators to two drugs already used to treat adults with breast, pancreatic, lung and other...

2014-02-01 23:02:26

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, applauds Seattle Seahawks Mascot Blitz the Hawk for delivering high-fives and hugs to pediatric brain cancer patients. New York, NY (PRWEB) February 01, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research, commends the Seattle Seahawks’ mascot, Blitz the Hawk, for reaching out to pediatric brain cancer patients. According to the January 17, 2014 article...

2013-12-17 08:26:44

BAYPORT, N.Y., Dec. 17, 2013 /PRNewswire/ -- Way back in In June 2008, Michael Desmond was diagnosed with a medulloblastoma, a cancerous brain tumor. After a long battle in treatment with high doses of radiation to his head, Michael Desmond survived. Without any money, he started collecting bikes from the garbage to resell on the Internet to fund an iPhone App he wanted to create. Currently he has 23 Music Apps available in the App store. Now he is looking to tell that story via a...

2013-10-05 23:04:39

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a new experimental approach to treating specific brain cancer developed by researchers at Sanford-Burnham. New York, NY (PRWEB) October 05, 2013 Voices Against Brain Cancer discusses a new experimental approach to treating a specific type of brain cancer called medulloblastoma. According to a September 25, 2013 article published by Science Daily titled “New Approach to Treating Human...

2013-09-23 13:02:17

Due to decreased side effects, it may also be cost-saving Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study...

2013-04-05 23:00:13

Voices Against Brain Cancer (VABC) responds to an article posted by Bioscience Technology detailing how the blockage of molecular pathways in the brain may be a contributing factor to the development of brain tumors. Bohemia, NY (PRWEB) April 05, 2013 On April 5, 2013, Voices Against Brain Cancer (VABC) responds to an article posted by Bioscience Technology detailing how the blockage of molecular pathways in the brain could be a contributing factor in the development of brain tumors. The...

2013-02-28 16:29:41

LEUVEN, Belgium, February 28, 2013 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), and co-development partner BioInvent International AB (OMXS: BINV), announce today the publication of a paper in the prestigious journal Cell, highlighting the potential of TB-403 to improve the treatment of medulloblastoma, the most common brain tumor in children. The Cell publication highlights for the first time a new mechanism of action, showing that PlGF plays a vital role...

2013-02-01 23:00:58

Following a Futurity.org article which reports on a new agent that allows doctors to see tumors more clearly on brain scans, a representative from Voices Against Brain Cancer applauds the technology. Bohemia, NY (PRWEB) February 01, 2013 On February 1, Voices Against Brain Cancer (VABC) responds to a new contrast agent that doctors are using to make brain tumors glow in order to see them more clearly and define their margins. A recent article from Futurity.org states that “the...

2013-01-23 10:20:01

The metabolic process which fuels the growth of many cancers has its origins in normal brain growth finds a new study published in BioMed Central's open access journal Cancer & Metabolism. Using knock-out mice the study shows that interfering with Hexokinase-2 (Hk2), an enzyme integral to glucose metabolism, reduces the aggressiveness of medulloblastoma, the most common malignant brain tumor in children, and allows long term survival of mice. Most cells only convert glucose to lactate...

2013-01-22 08:31:11

SANTA CLARA, Calif., Jan. 22, 2013 /PRNewswire/ -- NextBio today announced a translational research partnership with Emory University, Winship Cancer Institute and the Aflac Cancer Center aimed at using NextBio Clinical to interpret molecular and genomic data from children with medulloblastoma. The goal of the effort is to discover biomarkers that predict metastasis of the cancer in these young patients. Medulloblastoma is the most common brain tumor of childhood effecting around 500...